These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3870738)

  • 1. [Kinetics of the bacteriostatic activity of natural and synthetic chalcones on a strain of Staphylococcus aureus].
    Pappano NB; Puig de Centorbi O; Debattista NB; Calleri de Milan C; Borkowski EJ; Ferretti FH
    Rev Argent Microbiol; 1985; 17(1):27-32. PubMed ID: 3870738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriostatic action of synthetic polyhydroxylated chalcones against Escherichia coli.
    Alvarez Mde L; Zarelli VE; Pappano NB; Debattista NB
    Biocell; 2004 Apr; 28(1):31-4. PubMed ID: 15176739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microbial kinetics: experiences with Staphylococcus aureus ATCC 25 293 and bacteriostatic drugs].
    Pappano NB; Blanco SE; Debattista NB; Ferretti FH
    Rev Latinoam Microbiol; 1987; 29(4):367-72. PubMed ID: 3508321
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of prenylated benzaldehydes and their use in the synthesis of analogues of licochalcone A.
    Kromann H; Larsen M; Boesen T; Schønning K; Nielsen SF
    Eur J Med Chem; 2004 Nov; 39(11):993-1000. PubMed ID: 15501549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus.
    Liu XL; Xu YJ; Go ML
    Eur J Med Chem; 2008 Aug; 43(8):1681-7. PubMed ID: 18031869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic chalcone antibiotics. Design, synthesis, and mechanism of action.
    Nielsen SF; Larsen M; Boesen T; Schønning K; Kromann H
    J Med Chem; 2005 Apr; 48(7):2667-77. PubMed ID: 15801857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of antibacterial chalcones.
    Avila HP; Smânia Ede F; Monache FD; Smânia A
    Bioorg Med Chem; 2008 Nov; 16(22):9790-4. PubMed ID: 18951808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
    Batovska D; Parushev S; Stamboliyska B; Tsvetkova I; Ninova M; Najdenski H
    Eur J Med Chem; 2009 May; 44(5):2211-8. PubMed ID: 18584918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains.
    Alcaráz LE; Blanco SE; Puig ON; Tomás F; Ferretti FH
    J Theor Biol; 2000 Jul; 205(2):231-40. PubMed ID: 10873434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic analogs of natural prenylated and chromene chalcones.
    Lupi A; Delle Monache G; Delle Monache F; Marini-Bettòlo GB; Gonçalves de Lima O; De Méllo JF
    Farmaco Sci; 1977 Apr; 32(4):261-9. PubMed ID: 862880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibitory properties of ferrocene-substituted chalcones and aurones on bacterial and human cell cultures.
    Tiwari KN; Monserrat JP; Hequet A; Ganem-Elbaz C; Cresteil T; Jaouen G; Vessières A; Hillard EA; Jolivalt C
    Dalton Trans; 2012 Jun; 41(21):6451-7. PubMed ID: 22240736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships.
    De Vincenzo R; Scambia G; Benedetti Panici P; Ranelletti FO; Bonanno G; Ercoli A; Delle Monache F; Ferrari F; Piantelli M; Mancuso S
    Anticancer Drug Des; 1995 Sep; 10(6):481-90. PubMed ID: 7575989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists.
    Zwaagstra ME; Timmerman H; Tamura M; Tohma T; Wada Y; Onogi K; Zhang MQ
    J Med Chem; 1997 Mar; 40(7):1075-89. PubMed ID: 9089329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
    Loa J; Chow P; Zhang K
    Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory activity of prostaglandin E2 production by the synthetic 2'-hydroxychalcone analogues: Synthesis and SAR study.
    Tran TD; Park H; Kim HP; Ecker GF; Thai KM
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1650-3. PubMed ID: 19233646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pinocembrin chalcone: an antibacterial compound from Helichrysum trilineatum.
    Bremner PD; Meyer JJ
    Planta Med; 1998 Dec; 64(8):777. PubMed ID: 9933997
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility of Staphylococcus aureus strains toward combinations of oxacillin-2,4-dihydroxychalcone.
    Talia JM; Alvarez MA; Debattista NB; Pappano NB
    Folia Microbiol (Praha); 2009 Nov; 54(6):516-20. PubMed ID: 20140719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial synthesis and antibacterial evaluation of an indexed chalcone library.
    Ansari FL; Nazir S; Noureen H; Mirza B
    Chem Biodivers; 2005 Dec; 2(12):1656-64. PubMed ID: 17191962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chalcones as potent tyrosinase inhibitors: the effect of hydroxyl positions and numbers.
    Nerya O; Musa R; Khatib S; Tamir S; Vaya J
    Phytochemistry; 2004 May; 65(10):1389-95. PubMed ID: 15231412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molluscicidal activities of some synthetic chalcones.
    Adewunmi CO; Ogungbamila FO; Oluwadiya JO
    Planta Med; 1987 Feb; 53(1):110-2. PubMed ID: 3575504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.